Evidence map›Paper›PMID 41596599›Full record

ReviewInternational journal of molecular sciences2026

Advances in Colorectal Cancer Cell Biology and Clonal Evolution.

Sopozme Toghey, Elizabeth J Harvey-Jones, Jonathan D Towler, Charlotte J H Hafkamp, Irene Y Chong

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Targeting tumor transition windows.Exploration of targeted anti-tumor therapy · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sopozme TogheyDepartment of Radiotherapy, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK.ORCID 0009-0008-6545-9310
Elizabeth J Harvey-JonesDepartment of Radiotherapy, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK.
Jonathan D TowlerDepartment of Radiotherapy, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK.
Charlotte J H HafkampDepartment of Radiotherapy, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK.ORCID 0009-0007-6227-0806
Irene Y ChongDepartment of Radiotherapy, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) develops through evolutionary processes involving genomic alterations, epigenetic regulation, and microenvironmental interactions. While traditionally explained by the stepwise accumulation of driver mutations, contemporary evidence supports a 'Big Bang' model in which many early-arising clones expand simultaneously to establish extensive heterogeneity. We reviewed recent studies employing spatially resolved multi-omic sequencing of tumour glands combined with computational modelling. These approaches enable high-resolution reconstruction of clonal architecture, transcriptional states, and chromatin accessibility. Findings show that although early clonal mutations shape tumour expansion, gene expression variability can be independent of genetic ancestry and instead reflects phenotypic plasticity driven by microenvironmental cues. Epigenomic analyses identified recurrent somatic chromatin accessibility alterations in promotors and enhancers of oncogenic pathways, frequently in the absence of DNA mutations, suggesting alternative mechanisms of gene regulation. Immune-focused studies demonstrated that early silencing of antigen-presenting genes and loss of neoantigens facilitate immune escape despite active surveillance. CRC is shaped by an interplay of genome, epigenome, and immune evolution, with non-genetic mechanisms and tumour plasticity emerging as important drivers of progression and therapeutic resistance.

Indexed as

Clonal EvolutionColorectal NeoplasmsAnimalsEpigenesis, GeneticGene Expression Regulation, NeoplasticHumansMutationTumor Microenvironmentcell biology clonal evolutioncolorectaltranscriptional heterogeneity epigenetic regulation

Identifiers

PMID41596599
PMCPMC12841925

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.